UCSS study

Our Team

PI and Co-Investigators on the Utah Cancer Survivors Study

Mia Hashibe

Mia Hashibe

Mia Hashibe is an Associate Professor in the Department of Family and Preventive Medicine at the University of Utah and a Huntsman Cancer Institute (HCI) investigator. She is a member of the Cancer Control and Population Sciences Program.

Dr. Hashibe is interested in the molecular, global and cancer epidemiology of head and neck cancer, thyroid cancer and gynecologic cancers. She is the co-coordinator of the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Her studies include a head and neck cancer exome sequencing project, multicenter head and neck cancer case-control study in China, a lung cancer case-control study in Nepal, and a cancer survivors study in Utah.

Before joining HCI, Dr. Hashibe was a scientist with the International Agency for Research on Cancer in Lyon, France. She earned both a master's and doctoral degree from the University of California Los Angeles Fielding School of Public Health.

 

Amy Lee

Yuan-chin Amy Lee, PhD 
Adjunct Assistant Professor

Dr. Yuan-Chin Amy Lee graduated with her PhD degree in epidemiology at University of California, Los Angeles School of Public Health. She has been working closely with Dr. Mia Hashibe on smoking-related cancers, such as lung and head and neck cancers, at the International Agency for Research on Cancer in Lyon, France and at the University of Utah. She is interested in research that can be applied in the population. Currently, she is performing research on head and neck cancer etiology by conducting a case-control study in East Asia, and on head and neck cancer risk prediction modeling by utilizing the pooled database in the International Head and Neck Cancer Epidemiology Consortium.

Ken Smith

Ken Smith
Ken Smith, PhD, is an investigator at Huntsman Cancer Institute (HCI), a professor in the Department of Family and Consumer Studies at the University of Utah, and a member of the Cancer Control and Population Sciences Program.

As a family demographer and medical sociologist, Smith's research has focused on suspected psychosocial consequences of genetic testing, including psychological distress, sibling and spouse relationships, reproductive decision making, cancer screening behaviors, cancer risk communications, and life insurance purchasing behavior. This information could help genetic counselors provide more information about genetic testing to at-risk persons who are considering testing.

Smith uses the Utah Population Database (UPDB) to examine the relationship between family structure, mortality, and cancer risk over the past century. In collaboration with Geraldine Mineau, PhD, a principal investigator at HCI, and Lee Bean, PhD, emeritus professor in the University of Utah's sociology department, Smith is attempting to learn more about how the number, structure, and access to kin affect cancer incidence and mortality as well as overall longevity. In collaboration with Richard Cawthon, MD, PhD, in the University of Utah's Department of Human Genetics, and Richard Kerber, PhD, an HCI investigator, Smith is using the UPDB to identify and study families that exhibit exceptional longevity and that may also be aging so slowly that age-related diseases such as breast and prostate cancer are postponed to late ages. By studying exceptionally long-lived and normal-longevity control families in the UPDB, researchers may be able to provide information that could identify individuals at risk for premature death and early incidence of certain cancers so that they may have a better chance for early detection and curative treatment.

marcus monroe

Marcus Monroe, MD
Marcus Monroe, M.D., is an assistant professor in the Division of Otolaryngology—Head and Neck Surgery, Department of Surgery at the University of Utah School of Medicine. He is a surgeon and investigator with the Huntsman Cancer Institute where he specializes in the complex multidisciplinary care of patients with head and neck cancer.

His clinical practice involves treating patients with cancers of the upper aerodigestive tract (sinuses, oral cavity, pharynx and larynx), neck, thyroid, parathyroid, and salivary glands. In addition, he has a special interest in the treatment of melanoma and advanced skin cancers of the head and neck. He has experience with both traditional open and minimally-invasive procedures, including Transoral Robotic Surgery (TORS). Dr. Monroe believes that the best care comes when a team of specialists works together to create a treatment plan that is tailored to the individual patient. Because of this, he works closely with a team of head and neck cancer specialists, including medical and radiation oncologists, to determine the best possible treatment for each patient.

Dr. Monroe has published numerous articles and book chapters regarding cancers of the head and neck. His research interests include clinical trials for head and neck cancer, risk stratification in thyroid cancer, and survivorship issues following treatment for head and neck malignancies.

Dr. Monroe received his medical degree at the University of Missouri—Columbia School of Medicine and completed his residency training in Otolaryngology—Head and Neck Surgery at Oregon Health and Science University (OHSU) in Portland, Oregon. Prior to joining the faculty at the University of Utah, Dr. Monroe completed a 2-year fellowship in Head and Neck Surgical Oncology at the University of Texas M.D. Anderson Cancer Center.

Theresa Werner Theresa Werner, MD

Medical Director, Clinical Trials Office
Assistant Professor, Division of Oncology, Department of Medicine

Theresa L. Werner, M.D., is an assistant professor in the Division of Oncology, Department of Medicine, at the University Of Utah School Of Medicine, an Investigator at the Huntsman Cancer Institute, and a member of the Experimental Therapeutics Program. Dr. Werner is a specialist in adult hematology and medical oncology, and her main areas of interest include breast cancer and gynecologic malignancies (cancers of the ovary, uterus, cervix, and vagina).

Dr. Werner earned her bachelor’s degree from Indiana University in Bloomington, Indiana, and her medical degree from Indiana University School of Medicine, in Indianapolis, Indiana. She then completed a residency in internal medicine and a chief medical residency at the University Of Utah School Of Medicine, where she received awards for excellence in teaching and the clinical care of patients. Dr. Werner then completed a fellowship in hematology and medical oncology at the University of Utah and the Huntsman Cancer Institute. She is board certified in internal medicine, hematology, and oncology.

Dr. Werner is a member of the gynecologic and breast cancer programs at the Huntsman Cancer Institute. She sees patients with these types of cancers in her clinic as well as those patients at high risk for breast and ovarian cancer in the Family Cancer Assessment Clinic. Dr. Werner is a member of several professional societies including the American Society of Clinical Oncology, the Southwest Oncology Group, and the Gynecology Oncology Group, where she serves as a member of the Medical Oncology Committee. She also serves on the National Cancer Institute’s Cervical Cancer Task Force and the National Cancer Comprehensive Network (NCCN) Panel for Ovarian Cancer which defines national standards for the oncologic care of ovarian cancer. Dr. Werner is heavily involved in clinical and translational research and is active in the experimental therapeutics and phase one clinical trial program. Dr. Werner serves as the principal investigator for numerous clinical trials in breast and gynecologic cancers.

Kim Jaewhan Kim, PhD
Associate Professor
Patricia Ganz

Patricia Ganz, MD (UCLA)


Research Team

Sandi Edwards

Sandie Edwards

Sandra “Sandie” Edwards is a Research Associate in the Division of Epidemiology, Department of Family and Preventive Medicine at the University of Utah School of Medicine and a member of the Health Measurement and Survey Methods, CCTS Population Health Core. She has over 30-years of experience in survey methods and data collection including managing research studies using mail, telephone, face-to-face, audio-CASI, online, and mixed mode questionnaires. She is interested in epidemiologic methods and has published numerous articles on computerized data collection, study design, and participant recruiting.

Makenzie Hawkins

Makenzie Hawkins
Clinical Research Coordinator

Makenzie is working on her Master of Science in Public Health at the University of Utah and plans to graduate December 2015. Her thesis was focused on the health behaviors of cancer survivors after diagnosis. She has a strong educational background in health education and human development and has over 2 years of experience in clinical research. As Dr. Hashibe's clinical research coordinator, Makenzie is working on patient recruitment and data collection for the Head and Neck Cancer Susceptibility Genes Project. 

Sarah

Sarah Abdelaziz, Mstat
Biostatistician

Sarah Abdelaziz is a Biostatistician in Hashibe Group at the Huntsman Cancer Institute. She graduated with a Master of Science in Biostatistics from University of Utah. She is currently working with Dr. Hashibe on projects involving survivors of head and neck cancer and colorectal cancer.

Sean Soisson

Sean Soisson
PhD Student

Sean Soisson is a PhD student in the Division of Public Health at the University of Utah. He graduated with a master's degree in anthropology from Ohio State University. He is currently working with Dr. Hashibe on projects involving survivors of endometrial and ovarian cancer. He has been working with Dr. Lisa Cannon-Albright in the Division of Genetic Epidemiology on identifying genetic contributions to colorectal cancer since 2013.

Brenna

Brenna Blackburn, MPH
PhD Student

Brenna is a PhD student in Public Health planning to graduate in May 2017. For the Utah Cancer Survivor Study, she is focusing on late effects in thyroid cancer survivors. She received her Master of Public Health from the University of Arizona in 2012.
 

 

 
The information posted on this site is consistent with the research reviewed and approved by the University of Utah Institutional Review Board (IRB). However, the IRB has not reviewed all material posted on this site. Contact the IRB if you have questions regarding your rights as a research participant. Also contact the IRB if you have questions, complaint, or concerns which you do not feel you can discuss with the investigator. The University of Utah IRB may be reached by phone at (801) 581-3655 or by email at irb@hsc.utah.edu.